Gilles Avenard
Fondateur chez ACTICOR BIOTECH SAS
Profil
Gilles Avenard was the founder of Valerio Therapeutics SA, founded in 1997, where he held the title of Chief Operating Officer in 2010, and Acticor Biotech SAS, founded in 2013, where he held the title of Chief Executive Officer & Director.
He currently holds positions as Director at France Biotech Association, Independent Non-Executive Director at Minka Therapeutics SA, Director at Coretech 5 SA, and Member-Supervisory Board at Axoltis Pharma SA. Dr. Avenard previously worked as Medical Director-Development & Project Director at Hoechst Marion Roussel SA from 1990 to 1997, and as Director at Hemosystem SA and Hemarina SA. He also held the title of Director at Coretech 5 SA from 2019 to 2022.
Dr. Avenard's education includes a doctorate from Université Paris 1 Panthéon-Sorbonne.
Postes actifs de Gilles Avenard
| Sociétés | Poste | Début |
|---|---|---|
| ACTICOR BIOTECH SAS | Fondateur | 26/11/2013 |
| CORETECH 5 | Directeur/Membre du Conseil | - |
France Biotech Association
 France Biotech Association Miscellaneous Commercial ServicesCommercial Services France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin. | Directeur/Membre du Conseil | 06/08/2010 |
Minka Therapeutics SA
 Minka Therapeutics SA Pharmaceuticals: MajorHealth Technology Minka Therapeutics SA develops therapeutic products and diagnostic complementary to current antiretroviral therapy in the treatment of AIDS. The firm provides therapeutic and diagnostic solutions for diseases linked to the immune system through its research on immune dysregulations. The company was founded by Patrice Debre, Vincent Vieillard, Michel Klein, Joël Crouzet, and Robert L. Murphy in 2008 and is headquartered in Evry, France. | Directeur/Membre du Conseil | - |
| Axoltis Pharma SA | Directeur/Membre du Conseil | - |
Anciens postes connus de Gilles Avenard
| Sociétés | Poste | Fin |
|---|---|---|
| CORETECH 5 | Directeur/Membre du Conseil | 01/06/2022 |
| VALERIO THERAPEUTICS | Fondateur | 04/08/2010 |
| Hoechst Marion Roussel SA | Corporate Officer/Principal | 01/01/1997 |
Groupe hospitalier Pitié-Salpêtrière
 Groupe hospitalier Pitié-Salpêtrière Hospital/Nursing ManagementHealth Services Groupe hospitalier Pitié-Salpêtrière is a part of the AP-HP, which is the CHU of Ile-de-France and is based in Paris, France. The AP-HP has 38 hospitals that receive 8.3 million patients every year. The French company provides medical, social, and legal support to victims of violence through its Maison des Femmes program. The private company also has several research chairs in different fields and all of its clinical services are subject to regulatory certification by the Haute Autorité de Santé (HAS). The company uses indicators to regularly evaluate the quality and safety of the care it provides. The company also has a team of social workers who can help patients with their needs outside of the hospital. The company has protocols for cooperation between healthcare professionals to extend the scope of activities of paramedics while ensuring the quality and safety of care. | Corporate Officer/Principal | - |
| ░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Gilles Avenard
| Université Paris 1 Panthéon-Sorbonne | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| VALERIO THERAPEUTICS | Health Technology |
| ACTICOR BIOTECH SAS | Health Technology |
| CORETECH 5 | Process Industries |
| Entreprise privées | 7 |
|---|---|
| Hoechst Marion Roussel SA | Health Technology |
Hemosystem SA
 Hemosystem SA Medical SpecialtiesHealth Technology Hemosystem SA developed technologies to improve safety in the blood transfusion. The company was founded by Jean-Pierre Hermet in May 1999 and was headquartered in Marseille, France. | Health Technology |
France Biotech Association
France Biotech Association Miscellaneous Commercial ServicesCommercial Services France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin. | Commercial Services |
Hemarina SA
 Hemarina SA BiotechnologyHealth Technology Hemarina SA operates as a biotechnology company which develops oxygen carrier for therapeutic and industrial applications. It offers organ preservation, wound healing, hemoglobin oxygen-carrier, cell culture and bioproduction and other perspective products. The company was founded by Franck Zal, Elisabeth Leize, Morgane Rousselot and Laurent Meijer on March 26, 2007 and is headquartered in Morlaix, France. | Health Technology |
Minka Therapeutics SA
Minka Therapeutics SA Pharmaceuticals: MajorHealth Technology Minka Therapeutics SA develops therapeutic products and diagnostic complementary to current antiretroviral therapy in the treatment of AIDS. The firm provides therapeutic and diagnostic solutions for diseases linked to the immune system through its research on immune dysregulations. The company was founded by Patrice Debre, Vincent Vieillard, Michel Klein, Joël Crouzet, and Robert L. Murphy in 2008 and is headquartered in Evry, France. | Health Technology |
Groupe hospitalier Pitié-Salpêtrière
Groupe hospitalier Pitié-Salpêtrière Hospital/Nursing ManagementHealth Services Groupe hospitalier Pitié-Salpêtrière is a part of the AP-HP, which is the CHU of Ile-de-France and is based in Paris, France. The AP-HP has 38 hospitals that receive 8.3 million patients every year. The French company provides medical, social, and legal support to victims of violence through its Maison des Femmes program. The private company also has several research chairs in different fields and all of its clinical services are subject to regulatory certification by the Haute Autorité de Santé (HAS). The company uses indicators to regularly evaluate the quality and safety of the care it provides. The company also has a team of social workers who can help patients with their needs outside of the hospital. The company has protocols for cooperation between healthcare professionals to extend the scope of activities of paramedics while ensuring the quality and safety of care. | Health Services |
| Axoltis Pharma SA |
